Kodiak Sciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Kodiak Sciences Stock Summary

Kodiak Sciences competes with Cue Biopharma, Eliem Therapeutics, Inhibrx, and Molecular Partners. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. Kodiak Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.

Kodiak Sciences Key Financial Ratios

Kodiak Sciences Key Balance Sheet Accounts

Kodiak Sciences Key Income Statement Accounts

Kodiak Sciences Key Cash Accounts

Kodiak Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kodiak Sciences's current stock value. Our valuation model uses many indicators to compare Kodiak Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kodiak Sciences competition to find correlations between indicators driving Kodiak Sciences's intrinsic value. More Info.Kodiak Sciences is rated third overall in return on equity category among its peers. It also is rated third overall in return on asset category among its peers . At present, Kodiak Sciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Kodiak Sciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Kodiak Sciences Systematic Risk

Today, most investors in Kodiak Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Kodiak Sciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Kodiak Sciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Kodiak Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kodiak Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kodiak Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Kodiak Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kodiak Sciences's daily price indicators and compare them against related drivers.

When running Kodiak Sciences' price analysis, check to measure Kodiak Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kodiak Sciences is operating at the current time. Most of Kodiak Sciences' value examination focuses on studying past and present price action to predict the probability of Kodiak Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kodiak Sciences' price. Additionally, you may evaluate how the addition of Kodiak Sciences to your portfolios can decrease your overall portfolio volatility.